CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

BCR::ABL1 T315I — asciminib indicated

Gene: BCR::ABL1 · Type: mutation

Indications: Chronic myeloid leukemia

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
AsciminibChronic myeloid leukemiaINDICATED
FDA Label
Label
PonatinibChronic myeloid leukemiaINDICATED
FDA Label
Label